Literature DB >> 26908831

Chronic kidney disease prevalence in the general population: heterogeneity and concerns.

Luca De Nicola1, Carmine Zoccali2.   

Abstract

Entities:  

Year:  2015        PMID： 26908831     DOI： 10.1093/ndt/gfv427

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  30 in total

1.  Prevalence and recognition of chronic kidney disease in Stockholm healthcare.

Authors:  Alessandro Gasparini; Marie Evans; Josef Coresh; Morgan E Grams; Olof Norin; Abdul R Qureshi; Björn Runesson; Peter Barany; Johan Ärnlöv; Tomas Jernberg; Björn Wettermark; Carl G Elinder; Juan-Jesüs Carrero
Journal:  Nephrol Dial Transplant       Date:  2016-10-13       Impact factor: 5.992

2.  The predictive value of Klotho polymorphism, in addition to classical markers of CKD-MBD, for left ventricular hypertrophy in haemodialysis patients.

Authors:  Branislav Apostolović; Tatjana Cvetković; Nikola Stefanović; Svetlana Apostolović; Marija Anđelković Apostolović; Branka Mitić; Radmila Veličković Radovanović; Karolina Paunović; Aleksandra Ignjatović; Mina Cvetković; Nataša Stević; Dusica Pavlović
Journal:  Int Urol Nephrol       Date:  2019-06-11       Impact factor: 2.370

3.  Clinical predictors of hyponatremia in patients with heart failure according to severity of chronic kidney disease.

Authors:  Ivan Velat; Željko Bušić; Viktor Čulić
Journal:  Wien Klin Wochenschr       Date:  2022-05-17       Impact factor: 2.275

4.  Hispaglabridin B, a constituent of liquorice identified by a bioinformatics and machine learning approach, relieves protein-energy wasting by inhibiting forkhead box O1.

Authors:  Zeng-Yan Huang; Ling-Jun Wang; Jia-Jia Wang; Wen-Jun Feng; Zhong-Qi Yang; Shi-Hao Ni; Yu-Sheng Huang; Huan Li; Yi Yang; Ming-Qing Wang; Rong Hu; Heng Wan; Chan-Juan Wen; Shao-Xiang Xian; Lu Lu
Journal:  Br J Pharmacol       Date:  2018-12-04       Impact factor: 8.739

Review 5.  The global burden of chronic kidney disease: estimates, variability and pitfalls.

Authors:  Richard J Glassock; David G Warnock; Pierre Delanaye
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

6.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Infection       Date:  2018-09-25       Impact factor: 3.553

7.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  J Nephrol       Date:  2018-09-25       Impact factor: 3.902

8.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Intern Emerg Med       Date:  2018-09-25       Impact factor: 3.397

9.  The potential of N-glycosylation profiles as biomarkers for monitoring the progression of Type II diabetes mellitus towards diabetic kidney disease.

Authors:  Eric Adua; Enoch Odame Anto; Peter Roberts; Osei Sarfo Kantanka; Emmanuel Aboagye; Wei Wang
Journal:  J Diabetes Metab Disord       Date:  2018-11-17

10.  Clinical Decision Support and Optional Point of Care Testing of Renal Function for Safe Use of Antibiotics in Elderly Patients: A Retrospective Study in Community Pharmacy Practice.

Authors:  Mette Heringa; Annemieke Floor-Schreudering; Peter A G M De Smet; Marcel L Bouvy
Journal:  Drugs Aging       Date:  2017-11       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.